Please login to the form below

Not currently logged in
Email:
Password:

EMD Serono president James Hoyes joins consultants RxC

Takes up a role as executive partner at the US management consulting firm

RxC International EMD Serono James HoyesJames Hoyes has joined RxC International as an executive partner, having worked for the New Jersey management consulting firm as a senior advisor since 2014.

He was previously president of EMD Serono - as the US biopharma operations of Germany's Merck are known - having initially joined the company in 2004 as VP of neurology marketing.

Hoyes subsequently held roles as executive vice president, managing EMD Serono's neurology sales, marketing, comms, call centre and medical affairs operations, and as chief commercial officer.

Prior to joining EMD Serono, Hoyes held leadership positions with the likes of Serono, Elan and Sanofi.

In his new consultancy role he will provide advisory services to RxC's clients, work on corporate development initiatives in life sciences and implement key strategic initiatives to scale up the firm's global operations.

RxC International managing partner Subbarao Jayanthi said: “Jim's addition represents another milestone in the expansion of our business. He has an outstanding track record as a leader in the life sciences sector, and his deep strategic and executive leadership expertise will be invaluable to our clients.”

12th August 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics